Literature DB >> 1475054

Pharmacological properties of the homomeric alpha 7 receptor.

D Bertrand1, S Bertrand, M Ballivet.   

Abstract

The pharmacological properties of the alpha-bungarotoxin sensitive alpha 7 neuronal nicotinic acetylcholine receptor (nAChR) were studied upon reconstitution in Xenopus oocytes. Channels formed by alpha 7 are about 10-fold more sensitive to nicotine and cytisine than to ACh but are little, if at all, activated by the ganglionic agonist 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP). Tubocurarine (TC) was found to act as a non-competitive inhibitor, whereas dihydro-beta-erythroidine (DH beta E) behaves as a pure competitive inhibitor whose blockade is fast and fully reversible. In addition, the alpha 7 receptor displays a poor sensitivity to methonium salts. The pharmacological properties of the alpha 7 channels are readily distinguishable from those of other identified neuronal nicotinic receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1475054     DOI: 10.1016/0304-3940(92)90179-b

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  32 in total

1.  Cholinergic modulation of stellate cells in the mammalian ventral cochlear nucleus.

Authors:  K Fujino; D Oertel
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

2.  Neuronal nicotinic threonine-for-leucine 247 alpha7 mutant receptors show different gating kinetics when activated by acetylcholine or by the noncompetitive agonist 5-hydroxytryptamine.

Authors:  E Palma; L Maggi; F Eusebi; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-beta 4 nicotinic acetylcholine receptor subunits and functional expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta 4 subunits.

Authors:  K J Elliott; S B Ellis; K J Berckhan; A Urrutia; L E Chavez-Noriega; E C Johnson; G Veliçelebi; M M Harpold
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

4.  Two distinct nicotinic receptors, one pharmacologically similar to the vertebrate alpha7-containing receptor, mediate Cl currents in aplysia neurons.

Authors:  J Kehoe; J M McIntosh
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

5.  Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor beta subunits.

Authors:  S C Harvey; C W Luetje
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

6.  Diverse inhibitory actions of quaternary ammonium cholinesterase inhibitors on Torpedo nicotinic ACh receptors transplanted to Xenopus oocytes.

Authors:  Silvia Olivera-Bravo; Isabel Ivorra; Andrés Morales
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

7.  Expeditious synthesis, enantiomeric resolution, and enantiomer functional characterization of (4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide (4BP-TQS): an allosteric agonist-positive allosteric modulator of α7 nicotinic acetylcholine receptors.

Authors:  Ganesh A Thakur; Abhijit R Kulkarni; Jeffrey R Deschamps; Roger L Papke
Journal:  J Med Chem       Date:  2013-10-25       Impact factor: 7.446

8.  Rat neuronal nicotinic acetylcholine receptors containing alpha7 subunit: pharmacological properties of ligand binding and function.

Authors:  Yingxian Xiao; Galya R Abdrakhmanova; Maryna Baydyuk; Susan Hernandez; Kenneth J Kellar
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

9.  A novel nicotinic mechanism underlies β-amyloid-induced neuronal hyperexcitation.

Authors:  Qiang Liu; Xitao Xie; Ronald J Lukas; Paul A St John; Jie Wu
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

10.  Cell-autonomous inhibition of alpha 7-containing nicotinic acetylcholine receptors prevents death of parasympathetic neurons during development.

Authors:  Martin Hruska; Rae Nishi
Journal:  J Neurosci       Date:  2007-10-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.